Attached files
| file | filename |
|---|---|
| EX-32.3 - EX-32.3 - GoodRx Holdings, Inc. | gdrx-ex323_9.htm |
| EX-32.2 - EX-32.2 - GoodRx Holdings, Inc. | gdrx-ex322_11.htm |
| EX-31.3 - EX-31.3 - GoodRx Holdings, Inc. | gdrx-ex313_8.htm |
| EX-31.2 - EX-31.2 - GoodRx Holdings, Inc. | gdrx-ex312_10.htm |
| EX-31.1 - EX-31.1 - GoodRx Holdings, Inc. | gdrx-ex311_7.htm |
| EX-10.2 - EX-10.2 - GoodRx Holdings, Inc. | gdrx-ex102_6.htm |
| EX-10.1 - EX-10.1 - GoodRx Holdings, Inc. | gdrx-ex101_63.htm |
| 10-Q - 10-Q 1Q21 - GoodRx Holdings, Inc. | gdrx-10q_20210331.htm |
Exhibit 32.1
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of GoodRx Holdings, Inc. (the “Company”) for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
|
|
|
|
|
By: |
|
/s/ Douglas Hirsch |
|
|
|
|
|
Douglas Hirsch |
|
|
|
|
Director and Co-Chief Executive Officer (principal executive officer) |